An improved approach for confirmatory phase III population pharmacokinetic analysis.


In contrast to the traditional extensive exploratory approach, the authors propose a confirmatory approach to phase III population pharmacokinetics for regulatory submissions. In their approach, they recommend a prespecified primary analysis based on phase I/II data and phase III study design. Their approach also incorporates several specific sensitivity… (More)
DOI: 10.1177/0091270008318670